Recent global studies highlight how more adults than ever are turning to these therapies, with over one-third of new type 2 diabetes initiations now involving GLP-1-based medications such as semaglutide or tirzepatide by late 2023, changing both the clinical and home care landscape (study data)
Do not transfer tablets to another container, as this may affect stability and increase the risk of medication errors
Impacts of endocrine-disrupting chemicals on prostate function and cancer
[PUBMED Abstract] Petty EM, Bolognia JL, Bale AE, et al.: Cutaneous malignant melanoma and atypical moles associated with a constitutional rearrangement of chromosomes 5 and 9
With about three million Canadians taking GLP-1 drugs, according to a 2026 survey by Leger, many other dentists and their patients have questions, too